dwn12088
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 30, 2021 (NCT04888728)
Timeline
Indications
Studied for
Mechanism of action
- Proline--tRNA ligaseINHIBITOR
proRS inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05389215 | Phase 2 | Aug 30, 2022 | AIDS Malignancy Consortium, Daewoong Pharmaceutical Co. LTD. |
| NCT04888715 | Phase 1 | Jul 23, 2021 | CHA University, Daewoong Pharmaceutical Co. LTD. |
| NCT04888728 | Phase 1 | Jun 30, 2021 | Daewoong Pharmaceutical Co. LTD., Paik hospital |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daewoong Pharmaceutical Co. LTD. | For profit | 3 | 3 | 2 | 2021 |
| AIDS Malignancy Consortium | Academic/Hospital | 1 | 0 | 1 | 2022 |
| CHA University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Paik hospital | Academic/Hospital | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1